JNJ-64041575

DRUG2 trials

Sponsors

Janssen-Cilag International NV, Janssen Pharmaceutica N.V., Belgium

Conditions

HealthyRenal Insufficiency

Phase 1

A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adults

CompletedNCT03105986

Janssen-Cilag International NVHealthy

Start: 2017-04-05End: 2017-06-16Updated: 2018-08-13

A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal Function

CompletedNCT03189498

Janssen Pharmaceutica N.V., BelgiumRenal Insufficiency

Start: 2017-07-11End: 2017-12-06Updated: 2025-02-03